Table 2 Impact of baseline covariates on (1) odds of receiving ARB relative to ACEI and (2) follow up Hgb levels (Factors Used in Doubly Robust Analysis)
Effect on follow up Hgb in g/dL (95% CI) | ||||
|---|---|---|---|---|
Overall | ACEI | ARB | ||
Baseline covariate | OR (95% CI) for receiving ARB relative to ACEI | (N = 701) | (N = 519) | (N = 182) |
AGE | 1.00 (0.98, 1.02) | 0.00 (−0.01, 0.01) | −0.00 (−0.01, 0.01) | −0.00 (−0.02, 0.02) |
Sex (female) | 1.40 (0.96, 2.05) | −0.32 (−0.47, -0.17) | −0.29 (−0.47, -0.11) | −0.47 (−0.75, -0.20) |
Diabetes mellitus | 1.16 (0.81, 1.67) | 0.01 (−0.14, 0.15) | −0.03 (−0.20, 0.15) | 0.15 (−0.13, 0.42) |
Hypertension | 2.82 (1.12, 7.13) | 0.29 (−0.01, 0.58) | 0.21 (−0.12, 0.54) | 0.49 (−0.24, 1.22) |
CHF | 1.90 (0.98, 3.68) | 0.42 (0.14, 0.70) | 0.56 (0.20, 0.91) | 0.13 (−0.33, 0.58) |
Hgb (pre) | 0.89 (0.78, 1.02) | 0.59 ( 0.53, 0.64) | 0.60 (0.54, 0.66) | 0.57 (0.48, 0.66) |
CKD | 1.19 (0.75, 1.89) | −0.15 (−0.34, 0.04) | −0.09 (−0.31, 0.14) | −0.31 (−0.64, 0.03) |
Year of initiation of treatment | 0.86 (0.74, 1.01) | −0.05 (−0.11, 0.01) | −0.05 (−0.13, 0.02) | −0.03 (−0.15, 0.09) |